Physicians Financial Services Inc. Has $905,000 Stock Holdings in The Clorox Company (NYSE:CLX)

Physicians Financial Services Inc. reduced its position in The Clorox Company (NYSE:CLX) by 9.3% in the 3rd quarter, HoldingsChannel reports. The firm owned 5,555 shares of the company’s stock after selling 570 shares during the period. Physicians Financial Services Inc.’s holdings in Clorox were worth $905,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. SG Americas Securities LLC raised its holdings in Clorox by 1,525.7% in the 1st quarter. SG Americas Securities LLC now owns 65,612 shares of the company’s stock valued at $10,046,000 after acquiring an additional 61,576 shares during the period. Mizuho Markets Americas LLC lifted its stake in Clorox by 93.7% during the first quarter. Mizuho Markets Americas LLC now owns 72,053 shares of the company’s stock worth $11,032,000 after purchasing an additional 34,864 shares during the last quarter. CANADA LIFE ASSURANCE Co boosted its stake in Clorox by 15.2% in the first quarter. CANADA LIFE ASSURANCE Co now owns 141,622 shares of the company’s stock valued at $21,705,000 after buying an additional 18,687 shares in the last quarter. Advisors Asset Management Inc. boosted its stake in shares of Clorox by 257.5% in the 1st quarter. Advisors Asset Management Inc. now owns 11,228 shares of the company’s stock valued at $1,719,000 after purchasing an additional 8,087 shares in the last quarter. Finally, Catalyst Capital Advisors LLC acquired a new stake in Clorox in the third quarter valued at approximately $54,000. Institutional investors own 78.53% of the company’s stock.

Insider Activity

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the transaction, the executive vice president now owns 13,471 shares in the company, valued at approximately $2,229,719.92. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.57% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the company. Evercore ISI cut their price objective on Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a report on Monday, October 14th. Barclays lifted their price target on Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a research note on Friday, November 1st. DA Davidson upped their price objective on Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a research note on Monday. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and raised their price objective for the company from $155.00 to $170.00 in a report on Wednesday. Finally, Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and boosted their target price for the stock from $174.00 to $187.00 in a report on Tuesday, October 1st. Five equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the company. According to MarketBeat, Clorox presently has a consensus rating of “Hold” and an average target price of $155.00.

Clorox Trading Up 0.5 %

Shares of Clorox stock traded up $0.80 on Friday, hitting $163.57. 68,997 shares of the company’s stock traded hands, compared to its average volume of 1,239,096. The company has a fifty day moving average of $161.89 and a two-hundred day moving average of $146.58. The Clorox Company has a one year low of $127.60 and a one year high of $169.09. The company has a market capitalization of $20.25 billion, a price-to-earnings ratio of 56.74, a price-to-earnings-growth ratio of 3.02 and a beta of 0.41. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62.

Clorox (NYSE:CLX) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.50. The company had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. Clorox’s revenue for the quarter was up 27.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.49 EPS. As a group, sell-side analysts expect that The Clorox Company will post 6.81 earnings per share for the current year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd were given a dividend of $1.22 per share. The ex-dividend date of this dividend was Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.98%. Clorox’s dividend payout ratio (DPR) is presently 170.04%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.